InVivo Therapeutics Corporation Announces New Clinical Trial Site For Neuro-Spinal Scaffold

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that UC Davis Medical Center in Sacramento, CA has been added as a clinical site in the company’s ongoing IDE pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). The medical center serves a 65,000 square-mile territory that includes 33 counties and 6 million residents across northern and central California.

Help employers find you! Check out all the jobs and post your resume.

Back to news